Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × tremelimumab × Clear all

NCT03539822 2026-01-21

CAMILLA

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms

NCT03751761 2024-02-28

GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms